SGLT2 Inhibitors as the Backbone of Therapy for Cardiovascular and Renal Protection

J Cardiovasc Transl Res. 2024 Feb;17(1):227-229. doi: 10.1007/s12265-023-10415-4. Epub 2023 Jul 17.

Felice Gragnano^{1

2}, Fabrizia Terracciano^{3

4}, Paolo Calabrò^{3

4}

¹ Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Viale Abramo Lincoln 5, IT-81100, Caserta, Italy. felice.gragnano@unicampania.it.
² Division of Clinical Cardiology, A.O.R.N. "Sant'Anna e San Sebastiano", F. Palasciano, IT-81100, Caserta, Italy. felice.gragnano@unicampania.it.
³ Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Viale Abramo Lincoln 5, IT-81100, Caserta, Italy.
⁴ Division of Clinical Cardiology, A.O.R.N. "Sant'Anna e San Sebastiano", F. Palasciano, IT-81100, Caserta, Italy.

No abstract available

Publication types